ABSTRACT Background Advances in molecular and cell biology have led to a paradigm shift in cancer management. We implemented next‐generation sequencing (NGS) at our community‐based academic cancer center over a decade ago. We sought to optimize the use of genomics and understand its impact in identifying actionable gen...
G. Moorthy, A. Sereika, K. Kaul et al.· Cancer Medicine· 0 citations
The scope of pre-analytical and early analytical methods used in clinical molecular laboratories can have vast effects on the quality and turnaround time for solid tumor next-generation sequencing assays. To learn more about various approaches, a survey of 24 academic laboratories within the Genomics Organization for A...
M. David, Jennifer J. D. Morrissette, N. Brown et al.· Academic Pathology· 0 citations
Integrating pharmacogenomic results into the molecular tumor board review led to improved therapeutic efficacy, such as avoiding the use of tamoxifen due to an increased risk of treatment failure and better pain management by detecting reduced CYP2D6 activation.
D. Helseth, Nicholas Miller, Mathew Yang et al.· Cancers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.